X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (36) 36
male (24) 24
oncology (22) 22
middle aged (21) 21
adult (20) 20
female (20) 20
index medicus (20) 20
aged (16) 16
clinical neurology (14) 14
cancer (11) 11
medicine & public health (11) 11
treatment outcome (11) 11
glioblastoma (9) 9
brain (8) 8
care and treatment (8) 8
chemotherapy (8) 8
radiotherapy (8) 8
temozolomide (8) 8
cerebrospinal fluid (7) 7
follow-up studies (7) 7
neurology (7) 7
survival (7) 7
tumors (7) 7
drug therapy (6) 6
surgery (6) 6
aged, 80 and over (5) 5
analysis (5) 5
brain neoplasms - pathology (5) 5
brain neoplasms - therapy (5) 5
dacarbazine - analogs & derivatives (5) 5
magnetic resonance imaging (5) 5
medicine, general & internal (5) 5
patients (5) 5
young adult (5) 5
adjuvant temozolomide (4) 4
brain neoplasms - drug therapy (4) 4
brain tumors (4) 4
central nervous system (4) 4
clinical trials (4) 4
combined modality therapy (4) 4
dacarbazine - therapeutic use (4) 4
european organization (4) 4
glioblastoma - pathology (4) 4
glioblastoma multiforme (4) 4
glioma (4) 4
gliomas (4) 4
health aspects (4) 4
immunology (4) 4
infectious diseases (4) 4
management (4) 4
medical prognosis (4) 4
methotrexate (4) 4
pet imaging (4) 4
prospective studies (4) 4
quality of life (4) 4
retrospective studies (4) 4
rituximab (4) 4
studies (4) 4
survival analysis (4) 4
therapy (4) 4
adolescent (3) 3
analgesia (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
brain cancer (3) 3
brain neoplasms - mortality (3) 3
brain neoplasms - radiotherapy (3) 3
brain-tumors (3) 3
breakthrough pain (3) 3
cancer pain (3) 3
case studies (3) 3
central nervous system neoplasms - drug therapy (3) 3
chemotherapy, adjuvant (3) 3
cohort studies (3) 3
disease-free survival (3) 3
glioblastoma - therapy (3) 3
glioma - pathology (3) 3
health care sciences & services (3) 3
hematology (3) 3
hematology, oncology and palliative medicine (3) 3
hiv infections - drug therapy (3) 3
hiv-1 (3) 3
lymphoma (3) 3
malignant glioma (3) 3
malignant gliomas (3) 3
medicine (3) 3
neoplasm recurrence, local - drug therapy (3) 3
neoplasm staging (3) 3
neoplasms (3) 3
neoplasms - complications (3) 3
netherlands - epidemiology (3) 3
neurosciences (3) 3
nuclear medicine (3) 3
opioids (3) 3
phase-ii (3) 3
primary cns lymphoma (3) 3
prognosis (3) 3
radiation therapy (3) 3
radiology, nuclear medicine & medical imaging (3) 3
response assessment (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, ISSN 1470-2045, 2014, Volume 15, Issue 9, pp. 943 - 953
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2013, Volume 31, Issue 3, pp. 344 - 350
Journal Article
European Journal of Cancer, ISSN 0959-8049, 09/2014, Volume 50, Issue 13, pp. 2309 - 2318
Journal Article
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 04/2013, Volume 40, Issue 4, pp. 615 - 635
super(11)C-methionine (MET) is the most popular amino acid tracer used in PET imaging of brain tumours. Because of its characteristics, MET PET provides a high... 
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 04/2013, Volume 40, Issue 4, p. 615
  ^sup 11^C-methionine (MET) is the most popular amino acid tracer used in PET imaging of brain tumours. Because of its characteristics, MET PET provides a... 
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 11, pp. 1533 - 1542
Journal Article
Journal of Neurology, Neurosurgery and Psychiatry, ISSN 0022-3050, 01/2011, Volume 82, Issue 6, pp. 707 - 708
Journal Article
Journal Article
European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, 4/2013, Volume 40, Issue 4, pp. 615 - 635
Journal Article